Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News ESC 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Michael O'Riordan

September 01, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Daily News

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

L.A. McKeown

February 23, 2024

News Conference News AHA 2023

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

Caitlin E. Cox

November 14, 2023

News Daily News

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

L.A. McKeown

August 31, 2023

News Daily News

Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives

L.A. McKeown

March 24, 2023

News Daily News

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

L.A. McKeown

January 13, 2023

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

News Daily News

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

L.A. McKeown

August 20, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Opinion CV Team Dispatch

December 2020 News Roundup

L.A. McKeown

December 01, 2020

News Opinion CV Team Dispatch

August 2020 News Roundup

L.A. McKeown

August 01, 2020

News Daily News

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

L.A. McKeown

June 08, 2020

News Daily News

ARB Use Linked to Suicide in New Study, but Is the Finding Real?

Michael O'Riordan

October 18, 2019

News Opinion Off Script

Off Script: Implicit Bias Can Be a Matter of Life and Death—Let’s Do Something About It

Quinn Capers IV, MD

September 23, 2019

News Daily News

PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years

Todd Neale

August 23, 2019

News Daily News

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Marcus A. Banks

July 12, 2019

Advertisement

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

What’s Going to Be Hot at ESC Congress 2025?

June 2024 Dispatch for the CV Team

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

Seeing Sticker Price for HFrEF Meds Opens Door to Discussions

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

Pneumonia in HF Patients Is Common, Lethal, and Preventable

December 2020 News Roundup

August 2020 News Roundup

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

ARB Use Linked to Suicide in New Study, but Is the Finding Real?

Off Script: Implicit Bias Can Be a Matter of Life and Death—Let’s Do Something About It

PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content